Inhaled Nitric Oxide (iNO) Collaborative

Last modified by Lisa Stromquist on 2016/04/05 17:16


To establish a standardized approach for the delivery, utilization and weaning of Inhaled Nitric Oxide for neonatal and paediatric patients across Canada. This project will have a strong emphasis on quality and safe care for this specialized patient population.

In 2013 The Canadian Association of Paediatric Health Centres (CAPHC), in partnership with Medbuy Corporation established a National Collaborative to develop guidelines for the use of inhaled nitric oxide (iNO) in neonatal and paediatric patients.  This Collaborative included content experts: physicians, respiratory therapists, nurses and quality improvement leaders from across the country. 

CAPHC and the Inhaled Nitric Oxide Collaborative are proud to announce that the CAPHC Guidelines for Inhaled Nitric Oxide for both Neonates and Paediatrics: Dosing, Administration and Weaning, are now posted on the CAPHC Knowledge Exchange Network

We believe that the development and implementation of national standards will: 

  • Provide a focus for quality control and patient safety; 
  • Reduce variations in practice;
  • Promote efficient use of iNO; 
  • Result in cost savings 
per page of Page
The environment prevents the table from loading data.
Created by Ann Watkins on 2016/03/31 18:11

Latest Activity

14 Apr

12 Apr

07 Apr

06 Apr

01 Apr

23 Mar

16 Mar

15 Mar

13 Mar

  • 13 Mar, 08:00
    • ZoustildZoustild posted the message ZoustildZoustild posted the message
      Ff14 Gil Farming 2021

12 Mar

10 Mar

09 Mar

08 Mar

04 Mar

22 Feb

19 Feb

18 Feb

12 Feb

10 Feb

05 Feb

26 Jan

25 Jan

22 Jan

21 Jan

18 Jan

14 Jan

07 Jan

05 Jan

04 Jan

23 Dec 2020